Our results demonstrated that OM can inhibit the high glucose-induced renal tubal EMT by reducing the degradation of SnoN mediated by Arkadia and inhibiting activation of the TGF-β1/Smad signaling pathway. This evidence concerns the gene TGFB1 and ocular melanoma.